Welcome to the Department of Radiation Oncology

Message from James M. Metz, MD — Chairman

Penn Radiation Oncology is dedicated to a three-part mission of excellence in patient care, basic and translational research, and the education of residents and students. We are committed to delivering excellence in every area and as such we steadfastly believe that "Excellence is Standard."

Penn Radiation Oncology is one of the most comprehensive radiation oncology programs in the world. The outstanding faculty and staff, combined with Penn’s extensive collection of advanced technology, gives patients access to nearly every treatment option available for their cancer. The broad range of radiation treatments available include proton therapy, intensity-modulated radiation therapy (IMRT), high-dose rate (HDR) and low-dose rate brachytherapy, partial breast irradiation, stereotactic radiosurgery (SRS), and Gamma Knife radiation. With the Abramson Cancer Center of the University of Pennsylvania, Penn Radiation Oncology provides patient care at the Ruth and Raymond Perelman Center for Advanced Medicine and seven community-based sites.

Read more of the Message from the Chair »

News

  • Interactive Mobile Cancer Apps: Promising, But Formative Friday, March 17, 2023

    Mobile apps that allow cancer patients to self-report symptoms and outcome data have the potential to help improve care. Justin Bekelman, MD, a professor of Radiation Oncology and director of the Penn Center for Cancer Care Innovation, shared key questions researchers should address to find the best way to incorporate digital health care tools into cancer care.

    Healthcare In Europe

  • How One Doctor-Patient Relationship Could Change How Women Are Treated for Gynecologic Cancers Thursday, February 2, 2023

    Retired chemist Dalia Jakas credits radiation oncologist Neil Taunk with curing her uterine cancer without harming her quality of life. Now, she’s empowering his research into how treatment can be improved for future patients. Penn Medicine News Blog

  • Penn Medicine Expands Proton Therapy Reach Wednesday, February 1, 2023

    News coverage details Penn Medicine’s proton therapy expansion to Lancaster General Health and Virtua Voorhees in South Jersey, explains the differences between proton and photon radiation therapy, and shares one patient’s experience with a radiation therapy clinical trial for breast cancer. As a global leader in proton therapy, Penn Medicine has trained medical professionals around the world and is leading scientific research on the technology, including a nationwide, randomized clinical trial to compare proton and photon therapy for breast cancer treatment. James Metz, MD, the Henry K. Pancoast Professor and chair of Radiation Oncology, and Justin Bekelman, MD, a professor of Radiation Oncology and director of the Penn Center for Cancer Care Innovation, were quoted.

More News

Upcoming Events

    More Events